Strategic Blueprint, LLC Gsk PLC Transaction History

Strategic Blueprint, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$38.79 - $43.16 $1,978 - $2,201	-51 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $1,862 - $2,114	51 New	51 $2,000
Q3 2020 Oct 27, 2020	SELL	$38.11 - $42.99 $1.57 Million - $1.77 Million	-41,185 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$37.87 - $43.58 $72,445 - $83,368	1,913 Added 4.87%	41,185 $1.68 Million
Q1 2020 Apr 20, 2020	BUY	$32.47 - $48.83 $81,045 - $121,879	2,496 Added 6.79%	39,272 $1.49 Million
Q4 2019 Jan 10, 2020	SELL	$42.0 - $48.25 $50,484 - $57,996	-1,202 Reduced 3.16%	36,776 $1.73 Million
Q3 2019 Oct 16, 2019	BUY	$40.46 - $43.52 $32,165 - $34,598	795 Added 2.14%	37,978 $1.62 Million
Q2 2019 Jul 09, 2019	BUY	$39.4 - $42.7 $246,289 - $266,917	6,251 Added 20.21%	37,183 $1.49 Million
Q1 2019 Apr 10, 2019	BUY	$38.57 - $42.69 $1.19 Million - $1.32 Million	30,932 New	30,932 $1.29 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Blueprint, LLC with notifications on news.